Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO27553 | Derris scandens | Species | Fabaceae | Eukaryota |
PMID[21314138] |
|||
NPO27553 | Derris scandens | Species | Fabaceae | Eukaryota |
PMID[19969457] |
|||
NPO27553 | Derris scandens | Species | Fabaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT1419 | Organism | Tribolium castaneum | Tribolium castaneum | LC50 | > | 1 | ug/ml | 21314138 |
NPT2745 | Organism | Rhyzopertha dominica | Rhyzopertha dominica | LC50 | = | 0.74 | ug/ml | 21314138 |
NPT778 | Organism | Sitophilus oryzae | Sitophilus oryzae | LC50 | = | 0.45 | ug/ml | 21314138 |
NPT2721 | Organism | Callosobruchus chinensis | Callosobruchus chinensis | LC50 | = | 0.9 | ug/ml | 21314138 |
NPT2747 | Organism | Achaea janata | Achaea janata | Activity | = | 75.3 | % | 19969457 |
NPT2747 | Organism | Achaea janata | Achaea janata | Activity | = | 18.6 | % | 19969457 |
NPT2747 | Organism | Achaea janata | Achaea janata | Activity | = | 0 | % | 19969457 |
NPT2747 | Organism | Achaea janata | Achaea janata | Activity | = | 10.9 | % | 19969457 |
NPT2747 | Organism | Achaea janata | Achaea janata | Activity | = | 550.8 | ug | 19969457 |
NPT2747 | Organism | Achaea janata | Achaea janata | Activity | = | 514.2 | ug | 19969457 |
NPT2747 | Organism | Achaea janata | Achaea janata | LD50 | = | 5.28 | microg/cm2 | 19969457 |
NPT2747 | Organism | Achaea janata | Achaea janata | Activity | = | 86.4 | % | 19969457 |
NPT2747 | Organism | Achaea janata | Achaea janata | ED50 | = | 3.85 | microg/cm2 | 19969457 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 9.001 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | IC50 | = | 741.31 | nM | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Ki | = | 560 | nM | 23571415 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 13.79 | % | 23571415 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | IC50 | = | 1071.52 | nM | 23571415 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Ki | = | 590 | nM | 23571415 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC170812 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9925 | High Similarity | NPC71903 |
0.9565 | High Similarity | NPC295696 |
0.9559 | High Similarity | NPC310370 |
0.9559 | High Similarity | NPC183642 |
0.9291 | High Similarity | NPC57470 |
0.9286 | High Similarity | NPC71739 |
0.9259 | High Similarity | NPC131950 |
0.9248 | High Similarity | NPC32463 |
0.9231 | High Similarity | NPC103116 |
0.9225 | High Similarity | NPC180477 |
0.9225 | High Similarity | NPC249942 |
0.9225 | High Similarity | NPC297886 |
0.9161 | High Similarity | NPC469933 |
0.9161 | High Similarity | NPC161864 |
0.9161 | High Similarity | NPC208303 |
0.9111 | High Similarity | NPC307289 |
0.9097 | High Similarity | NPC469932 |
0.9091 | High Similarity | NPC142863 |
0.9091 | High Similarity | NPC140120 |
0.9085 | High Similarity | NPC469953 |
0.9078 | High Similarity | NPC214236 |
0.9078 | High Similarity | NPC62840 |
0.9078 | High Similarity | NPC59739 |
0.9078 | High Similarity | NPC299080 |
0.9078 | High Similarity | NPC293852 |
0.9078 | High Similarity | NPC36181 |
0.9078 | High Similarity | NPC78803 |
0.9078 | High Similarity | NPC217083 |
0.9034 | High Similarity | NPC151973 |
0.9021 | High Similarity | NPC470322 |
0.9021 | High Similarity | NPC154217 |
0.9014 | High Similarity | NPC112791 |
0.9014 | High Similarity | NPC94794 |
0.9014 | High Similarity | NPC470296 |
0.9014 | High Similarity | NPC87609 |
0.9014 | High Similarity | NPC188632 |
0.9014 | High Similarity | NPC196459 |
0.8993 | High Similarity | NPC37428 |
0.8993 | High Similarity | NPC35501 |
0.8993 | High Similarity | NPC278600 |
0.8993 | High Similarity | NPC144512 |
0.8993 | High Similarity | NPC137262 |
0.8993 | High Similarity | NPC221046 |
0.8993 | High Similarity | NPC47040 |
0.8986 | High Similarity | NPC223616 |
0.8966 | High Similarity | NPC164205 |
0.8966 | High Similarity | NPC19238 |
0.8966 | High Similarity | NPC104236 |
0.8958 | High Similarity | NPC201731 |
0.8958 | High Similarity | NPC97716 |
0.8958 | High Similarity | NPC104406 |
0.8958 | High Similarity | NPC237635 |
0.8958 | High Similarity | NPC79469 |
0.8958 | High Similarity | NPC24673 |
0.8951 | High Similarity | NPC469935 |
0.8951 | High Similarity | NPC1886 |
0.8951 | High Similarity | NPC178627 |
0.8951 | High Similarity | NPC196137 |
0.8951 | High Similarity | NPC319752 |
0.8944 | High Similarity | NPC226636 |
0.8944 | High Similarity | NPC11561 |
0.8936 | High Similarity | NPC150522 |
0.8936 | High Similarity | NPC221173 |
0.8936 | High Similarity | NPC159275 |
0.8936 | High Similarity | NPC241100 |
0.8913 | High Similarity | NPC61499 |
0.8897 | High Similarity | NPC266572 |
0.8897 | High Similarity | NPC161191 |
0.8897 | High Similarity | NPC6511 |
0.8897 | High Similarity | NPC189087 |
0.8897 | High Similarity | NPC244407 |
0.8897 | High Similarity | NPC321623 |
0.8889 | High Similarity | NPC83357 |
0.8889 | High Similarity | NPC195621 |
0.8889 | High Similarity | NPC470647 |
0.8889 | High Similarity | NPC267375 |
0.8889 | High Similarity | NPC214774 |
0.8889 | High Similarity | NPC20488 |
0.8889 | High Similarity | NPC67805 |
0.8889 | High Similarity | NPC312973 |
0.8889 | High Similarity | NPC142405 |
0.8889 | High Similarity | NPC475052 |
0.8889 | High Similarity | NPC301276 |
0.8889 | High Similarity | NPC181388 |
0.8889 | High Similarity | NPC111786 |
0.8889 | High Similarity | NPC246948 |
0.8889 | High Similarity | NPC176229 |
0.8889 | High Similarity | NPC474161 |
0.8889 | High Similarity | NPC476088 |
0.8889 | High Similarity | NPC88964 |
0.8889 | High Similarity | NPC54577 |
0.8881 | High Similarity | NPC219915 |
0.8881 | High Similarity | NPC243688 |
0.8881 | High Similarity | NPC38219 |
0.8873 | High Similarity | NPC470555 |
0.8873 | High Similarity | NPC110969 |
0.8873 | High Similarity | NPC205006 |
0.8873 | High Similarity | NPC103362 |
0.8873 | High Similarity | NPC118840 |
0.8873 | High Similarity | NPC147688 |
0.8873 | High Similarity | NPC156590 |
0.8873 | High Similarity | NPC282300 |
0.8873 | High Similarity | NPC64908 |
0.8872 | High Similarity | NPC168259 |
0.8865 | High Similarity | NPC220062 |
0.8865 | High Similarity | NPC18260 |
0.8865 | High Similarity | NPC155552 |
0.8865 | High Similarity | NPC78913 |
0.8865 | High Similarity | NPC55018 |
0.8865 | High Similarity | NPC301217 |
0.8865 | High Similarity | NPC53181 |
0.8865 | High Similarity | NPC216978 |
0.8865 | High Similarity | NPC96565 |
0.8865 | High Similarity | NPC217186 |
0.8865 | High Similarity | NPC303633 |
0.8857 | High Similarity | NPC148738 |
0.8857 | High Similarity | NPC327612 |
0.8857 | High Similarity | NPC332594 |
0.8857 | High Similarity | NPC319870 |
0.8857 | High Similarity | NPC73078 |
0.8836 | High Similarity | NPC5173 |
0.8832 | High Similarity | NPC469956 |
0.8828 | High Similarity | NPC166757 |
0.8828 | High Similarity | NPC110303 |
0.8828 | High Similarity | NPC283234 |
0.8828 | High Similarity | NPC14001 |
0.8828 | High Similarity | NPC23728 |
0.8828 | High Similarity | NPC473077 |
0.8828 | High Similarity | NPC296998 |
0.8819 | High Similarity | NPC287275 |
0.8819 | High Similarity | NPC311741 |
0.8819 | High Similarity | NPC234629 |
0.8815 | High Similarity | NPC185066 |
0.8803 | High Similarity | NPC235239 |
0.8803 | High Similarity | NPC475680 |
0.8803 | High Similarity | NPC270883 |
0.8803 | High Similarity | NPC172986 |
0.8803 | High Similarity | NPC305355 |
0.8803 | High Similarity | NPC261227 |
0.8794 | High Similarity | NPC17848 |
0.8794 | High Similarity | NPC201395 |
0.8786 | High Similarity | NPC471069 |
0.8786 | High Similarity | NPC471068 |
0.8776 | High Similarity | NPC471984 |
0.8776 | High Similarity | NPC474735 |
0.8776 | High Similarity | NPC188403 |
0.8768 | High Similarity | NPC55147 |
0.8768 | High Similarity | NPC1220 |
0.8768 | High Similarity | NPC291551 |
0.8768 | High Similarity | NPC205797 |
0.8768 | High Similarity | NPC141822 |
0.8768 | High Similarity | NPC469952 |
0.8768 | High Similarity | NPC54503 |
0.8768 | High Similarity | NPC241165 |
0.8768 | High Similarity | NPC142563 |
0.8768 | High Similarity | NPC83535 |
0.8768 | High Similarity | NPC469955 |
0.8767 | High Similarity | NPC160821 |
0.8767 | High Similarity | NPC296869 |
0.8767 | High Similarity | NPC132592 |
0.8759 | High Similarity | NPC124729 |
0.8759 | High Similarity | NPC220418 |
0.875 | High Similarity | NPC214166 |
0.875 | High Similarity | NPC18585 |
0.875 | High Similarity | NPC478086 |
0.875 | High Similarity | NPC474289 |
0.875 | High Similarity | NPC166138 |
0.875 | High Similarity | NPC106985 |
0.875 | High Similarity | NPC134360 |
0.875 | High Similarity | NPC316816 |
0.8741 | High Similarity | NPC229916 |
0.8741 | High Similarity | NPC14871 |
0.8732 | High Similarity | NPC23257 |
0.8732 | High Similarity | NPC472343 |
0.8731 | High Similarity | NPC93219 |
0.8731 | High Similarity | NPC202594 |
0.8731 | High Similarity | NPC244495 |
0.8731 | High Similarity | NPC232692 |
0.8723 | High Similarity | NPC471070 |
0.8723 | High Similarity | NPC471071 |
0.8723 | High Similarity | NPC471072 |
0.8722 | High Similarity | NPC315807 |
0.8716 | High Similarity | NPC312549 |
0.8716 | High Similarity | NPC209142 |
0.8716 | High Similarity | NPC290671 |
0.8714 | High Similarity | NPC317045 |
0.8714 | High Similarity | NPC246177 |
0.8705 | High Similarity | NPC27643 |
0.8699 | High Similarity | NPC285748 |
0.8699 | High Similarity | NPC282335 |
0.8699 | High Similarity | NPC218300 |
0.8696 | High Similarity | NPC175159 |
0.8696 | High Similarity | NPC19157 |
0.869 | High Similarity | NPC131568 |
0.869 | High Similarity | NPC216538 |
0.869 | High Similarity | NPC278175 |
0.869 | High Similarity | NPC209040 |
0.869 | High Similarity | NPC131579 |
0.869 | High Similarity | NPC257236 |
0.869 | High Similarity | NPC273538 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC170812 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8803 | High Similarity | NPD3750 | Approved |
0.8768 | High Similarity | NPD5123 | Clinical (unspecified phase) |
0.8768 | High Similarity | NPD5124 | Phase 1 |
0.869 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.869 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.8686 | High Similarity | NPD6859 | Clinical (unspecified phase) |
0.8593 | High Similarity | NPD2797 | Approved |
0.8591 | High Similarity | NPD7411 | Suspended |
0.8571 | High Similarity | NPD422 | Phase 1 |
0.8519 | High Similarity | NPD3225 | Approved |
0.8487 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8472 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.8451 | Intermediate Similarity | NPD3748 | Approved |
0.8417 | Intermediate Similarity | NPD3268 | Approved |
0.8333 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8333 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8312 | Intermediate Similarity | NPD7075 | Discontinued |
0.8289 | Intermediate Similarity | NPD6801 | Discontinued |
0.8288 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.8286 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.8276 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8235 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8235 | Intermediate Similarity | NPD7819 | Suspended |
0.82 | Intermediate Similarity | NPD5403 | Approved |
0.8194 | Intermediate Similarity | NPD1510 | Phase 2 |
0.8194 | Intermediate Similarity | NPD4308 | Phase 3 |
0.8182 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.8169 | Intermediate Similarity | NPD1240 | Approved |
0.8158 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8156 | Intermediate Similarity | NPD1296 | Phase 2 |
0.8143 | Intermediate Similarity | NPD4908 | Phase 1 |
0.8138 | Intermediate Similarity | NPD2796 | Approved |
0.8138 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8138 | Intermediate Similarity | NPD2935 | Discontinued |
0.8134 | Intermediate Similarity | NPD1548 | Phase 1 |
0.8121 | Intermediate Similarity | NPD6799 | Approved |
0.8117 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8113 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8105 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.8077 | Intermediate Similarity | NPD3749 | Approved |
0.8069 | Intermediate Similarity | NPD7033 | Discontinued |
0.8067 | Intermediate Similarity | NPD5401 | Approved |
0.8058 | Intermediate Similarity | NPD3266 | Approved |
0.8058 | Intermediate Similarity | NPD1203 | Approved |
0.8058 | Intermediate Similarity | NPD3267 | Approved |
0.8056 | Intermediate Similarity | NPD1607 | Approved |
0.8027 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8013 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7973 | Intermediate Similarity | NPD1243 | Approved |
0.7963 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7962 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7945 | Intermediate Similarity | NPD2799 | Discontinued |
0.7922 | Intermediate Similarity | NPD6599 | Discontinued |
0.7917 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7902 | Intermediate Similarity | NPD2313 | Discontinued |
0.7902 | Intermediate Similarity | NPD6798 | Discontinued |
0.7899 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7887 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7885 | Intermediate Similarity | NPD2801 | Approved |
0.7881 | Intermediate Similarity | NPD1511 | Approved |
0.7853 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7843 | Intermediate Similarity | NPD920 | Approved |
0.7842 | Intermediate Similarity | NPD9717 | Approved |
0.7834 | Intermediate Similarity | NPD4288 | Approved |
0.7834 | Intermediate Similarity | NPD5402 | Approved |
0.7834 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7832 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7821 | Intermediate Similarity | NPD1934 | Approved |
0.7815 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.78 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.78 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7778 | Intermediate Similarity | NPD1512 | Approved |
0.777 | Intermediate Similarity | NPD6099 | Approved |
0.777 | Intermediate Similarity | NPD6100 | Approved |
0.7764 | Intermediate Similarity | NPD6232 | Discontinued |
0.7762 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7733 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7714 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7714 | Intermediate Similarity | NPD1608 | Approved |
0.7712 | Intermediate Similarity | NPD2534 | Approved |
0.7712 | Intermediate Similarity | NPD2533 | Approved |
0.7712 | Intermediate Similarity | NPD2532 | Approved |
0.7712 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7712 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7702 | Intermediate Similarity | NPD6959 | Discontinued |
0.7687 | Intermediate Similarity | NPD5535 | Approved |
0.7682 | Intermediate Similarity | NPD7003 | Approved |
0.7658 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7655 | Intermediate Similarity | NPD3764 | Approved |
0.7651 | Intermediate Similarity | NPD5953 | Discontinued |
0.7651 | Intermediate Similarity | NPD4476 | Approved |
0.7651 | Intermediate Similarity | NPD4477 | Approved |
0.7643 | Intermediate Similarity | NPD1535 | Discovery |
0.7636 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7628 | Intermediate Similarity | NPD3226 | Approved |
0.7628 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD7473 | Discontinued |
0.7619 | Intermediate Similarity | NPD6355 | Discontinued |
0.7616 | Intermediate Similarity | NPD2800 | Approved |
0.7609 | Intermediate Similarity | NPD1894 | Discontinued |
0.7605 | Intermediate Similarity | NPD6559 | Discontinued |
0.7603 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7568 | Intermediate Similarity | NPD6651 | Approved |
0.7562 | Intermediate Similarity | NPD3882 | Suspended |
0.7561 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7561 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7561 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7551 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7547 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7546 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7535 | Intermediate Similarity | NPD4749 | Approved |
0.7532 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.753 | Intermediate Similarity | NPD7054 | Approved |
0.7517 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD6971 | Discontinued |
0.75 | Intermediate Similarity | NPD17 | Approved |
0.7485 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7485 | Intermediate Similarity | NPD7472 | Approved |
0.7483 | Intermediate Similarity | NPD1283 | Approved |
0.7483 | Intermediate Similarity | NPD6003 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD6002 | Phase 3 |
0.7483 | Intermediate Similarity | NPD6005 | Phase 3 |
0.7483 | Intermediate Similarity | NPD2346 | Discontinued |
0.7483 | Intermediate Similarity | NPD6006 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD6004 | Phase 3 |
0.7482 | Intermediate Similarity | NPD9545 | Approved |
0.747 | Intermediate Similarity | NPD3818 | Discontinued |
0.7469 | Intermediate Similarity | NPD919 | Approved |
0.7468 | Intermediate Similarity | NPD6502 | Phase 2 |
0.7456 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7456 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7448 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7447 | Intermediate Similarity | NPD3847 | Discontinued |
0.744 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.744 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7436 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7436 | Intermediate Similarity | NPD6273 | Approved |
0.7432 | Intermediate Similarity | NPD1613 | Approved |
0.7432 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7423 | Intermediate Similarity | NPD5494 | Approved |
0.7419 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7419 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7415 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7405 | Intermediate Similarity | NPD7458 | Discontinued |
0.7405 | Intermediate Similarity | NPD8158 | Clinical (unspecified phase) |
0.74 | Intermediate Similarity | NPD7097 | Phase 1 |
0.7396 | Intermediate Similarity | NPD7251 | Discontinued |
0.7389 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7383 | Intermediate Similarity | NPD1933 | Approved |
0.7383 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7383 | Intermediate Similarity | NPD4340 | Discontinued |
0.7379 | Intermediate Similarity | NPD2798 | Approved |
0.7378 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7376 | Intermediate Similarity | NPD4626 | Approved |
0.7375 | Intermediate Similarity | NPD37 | Approved |
0.7372 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7372 | Intermediate Similarity | NPD1241 | Discontinued |
0.7368 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7365 | Intermediate Similarity | NPD4062 | Phase 3 |
0.7362 | Intermediate Similarity | NPD6234 | Discontinued |
0.7355 | Intermediate Similarity | NPD6666 | Approved |
0.7355 | Intermediate Similarity | NPD6667 | Approved |
0.7353 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7347 | Intermediate Similarity | NPD7095 | Approved |
0.7346 | Intermediate Similarity | NPD4965 | Approved |
0.7346 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7346 | Intermediate Similarity | NPD4966 | Approved |
0.7345 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7342 | Intermediate Similarity | NPD1653 | Approved |
0.7338 | Intermediate Similarity | NPD9493 | Approved |
0.7303 | Intermediate Similarity | NPD5405 | Approved |
0.7303 | Intermediate Similarity | NPD5404 | Approved |
0.7303 | Intermediate Similarity | NPD5406 | Approved |
0.7303 | Intermediate Similarity | NPD5408 | Approved |
0.7297 | Intermediate Similarity | NPD411 | Approved |
0.7289 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7279 | Intermediate Similarity | NPD2614 | Approved |
0.7278 | Intermediate Similarity | NPD7427 | Discontinued |
0.7273 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD1281 | Approved |
0.7267 | Intermediate Similarity | NPD447 | Suspended |
0.7267 | Intermediate Similarity | NPD230 | Phase 1 |
0.7262 | Intermediate Similarity | NPD5940 | Clinical (unspecified phase) |
0.726 | Intermediate Similarity | NPD1019 | Discontinued |
0.7255 | Intermediate Similarity | NPD2344 | Approved |
0.7254 | Intermediate Similarity | NPD1778 | Approved |
0.725 | Intermediate Similarity | NPD6585 | Discontinued |
0.7246 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7244 | Intermediate Similarity | NPD7440 | Discontinued |
0.723 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7211 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7208 | Intermediate Similarity | NPD2424 | Discontinued |
0.7205 | Intermediate Similarity | NPD5890 | Approved |
0.7205 | Intermediate Similarity | NPD5889 | Approved |
0.7203 | Intermediate Similarity | NPD3496 | Discontinued |
0.72 | Intermediate Similarity | NPD2979 | Phase 3 |
0.7192 | Intermediate Similarity | NPD1164 | Approved |
0.7183 | Intermediate Similarity | NPD5691 | Approved |
0.7179 | Intermediate Similarity | NPD2354 | Approved |
0.7164 | Intermediate Similarity | NPD9697 | Approved |
PubChem CID   | 54676535 |
ChEMBL   | CHEMBL1603825 |
ZINC   |
Molecular Weight:   | 434.17 |
ALogP:   | 1.8911 |
MLogP:   | 3.66 |
XLogP:   | 4.875 |
# Rotatable Bonds:   | 11 |
Polar Surface Area:   | 85.22 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 2 |
# Rings:   | 4 |
# Heavy Atoms:   | 32 |